HempCBD Investor Magazine Issue #3 - July / August 2020 | Page 44

Q

HCI: Can you provide us with a revenue breakdown? In other words, what % of your revenues are derived from growing, extracting, processing, cloning, wholesaling, and retailing?

A

GZP: Approximately 60% of our products are private label. It’s a complicated question, but I would say 1/3 is private label, 1/3 is selling in our brick and mortar and partner stores and 1/3 in added value services we offer like lab testing, product development, and consulting for hemp growers in our cooperatives.

Q

HCI: What experience does your management team possess that would help investors sleep at night?

A

GZP: Personally, I have 25 years of experience building companies. My team has decades of combined experience in medical, mechanical, and business management.

Q

HCI: What are your revenue streams? Can you explain your revenue model? How do you plan on making money?

A

GZP: We private label CBD products for other CBD companies as well as manufacture our own brand of products. We have direct retail distribution at our store as well as sell wholesale to other stores. Also, we process hemp and do lab testing, these are all additional revenue streams that we have developed.

Q

A

HCI: Seems like the market is already saturated with many competitors? Who are your competitors? What are your disadvantages? What are your advantages?

GZP: As we talked about at the start of this interview, Greenzone stands out by having the ability to provide high quality and highly effective products because we own the entire supply chain.